DE30: Bayer gains on favourable court verdict

9:29 AM 16 July 2019

Summary:
- European Parliament to vote on the candidacy of Ursula von der Leyen today
- DAX (DE30) trades a notch below the 12400 pts handle
- Deutsche Bank (DBK.DE) reaffirmed at BBB+ at S&P

Stock market indices from the Western Europe are trading higher on Tuesday morning. Shares from the United Kingdom and Belgium advance the most while equities from Russia and Sweden can be found among the biggest laggards.  Healthcare stocks lead higher while carmakers and real estate companies underperform the most.

DE30 tries to definitely snap a losing streak and add to yesterday’s gains. The index is trading in the vicinity of the 33-period moving average (H4 interval) and slightly below the 12520 pts handle marked by peak from 20 June 2019. Note that in case declines do not deepen structure of higher lows will be intact and thus one could expect an upward move to resume. Source: xStation5

European Parliament to vote on the candidacy of Ursula von der Leyen today

The European Parliament will vote today on the candidacy of Ursula von der Leyen for the post of the European Commission chief. The ballot will be held at 5:00 pm BST. However, there is still a chance that she will fail to secure a majority of the votes. Some of the groups within the European Parliament may oppose her candidacy in a sort of revenge for rejecting their own candidates. Nevertheless, von der Leyen made a bulk of promises yesterday, including minimum EU wage and growth-oriented fiscal policy, in a bid to win their support. Results of the vote should be known around 7:00 pm BST. However, in case she fails to get backing of the European Parliament, the EU politics may be thrown into a little chaos. In such a situation the European leaders would have to come up with another candidate within a month and given how did they struggle to choose von der Leyen, it may not be an easy task.

DAX members at 9:06 am BST. Source: Bloomberg

Company News

Bayer (BAYN.DE) is one of the best performing DAX members at the beginning of Tuesday’s session. The German chemical company gains on the favourable court verdict awarded to its subsidiary, Monsanto. Court in San Francisco slashed the punitive portion of the fine in the Roundup case from $75 million to $20 million. However, the court slashed the fine because it found it miscalculated, not because it found the company any less guilty than previously. Given that Monsanto is facing hundreds or even thousands of similar cases, any ruling confirming company’s guilty risks becoming judicial precedent for other cases.

On the other hand, Daimler (DAI.DE) can be found among DAX biggest laggards. Goldman Sachs, major US investment bank, started issuing recommendations for the stock. The Bank initiated with a “sell” rating on Daimler and a price target was set at €42, implying around 10% decline against yesterday’s close.

Deutsche Bank (DBK.DE) shares are trading higher today following positive action from the S&P rating agency. S&P affirmed Deutsche Bank’s long-term rating at BBB+ with outlook remaining stable. The agency praised lender’s turnaround plans saying downsizing is “logical and necessary response to the deteriorated operating environment that the bank faces”. The agency also said it is confident that management is able to meet financial targets and projections it has set.

Deutsche Bank (DBK.DE) failed to break above the resistance zone ranging €7.10-€7.30 at the beginning of the month. The subsequent pullback was halted at the 50-session moving average (green line on the chart above). Now the stock is on the rise for another consecutive day and eyes another test of the aforementioned price zone. In case a break higher is delivered, bulls’ attention will shift to 200-session moving average (purple line). Source: xStation5 

Share:
Back

Join over 1 600 000 XTB Group Clients from around the world

The financial instruments we offer, especially CFDs, can be highly risky. Fractional Shares (FS) is an acquired from XTB fiduciary right to fractional parts of stocks and ETFs. FS are not a separate financial instrument. The limited corporate rights are associated with FS.
This page was not created for investors residing in Brazil. This brokerage is not authorized by the Comissão de Valores Mobiliários (CVM) or the Brazilian Central Bank (BCB). The content of this page should not be characterized as an investment offer in Brazil or for investors residing in that country.
Losses can exceed deposits